MNG stock rises on strong FY24 results and upbeat targets Investing.com -- Shares of M&G Plc (LON:MNG) climbed 3.21% following the announcement of solid FY24 operating results and optimistic future targets. The company reported an adjusted operating profit and operating capital generation that surpassed expectations, driven by non-underlying items such as foreign exchange gains and a one-off in shareholder annuities. The adjusted operating profit for the fiscal year came in at £837 million, outpacing the consensus of £769 million and RBC estimates of £781 million. The firm's Solvency II ratio, a measure of capital adequacy, stood at 223%, exceeding the consensus by 7 percentage points. This result was supported by the operating capital generation beat, which was reported at £933 million against a consensus of £916 million. However, asset management net flows were weaker than expected, with a £0.9 billion outflow compared to the consensus of a £0.1 billion outflow. Looking ahead, MNG has set ambitious targets for the FY25-27 period, including an average annual adjusted operating profit growth of at least 5%, which suggests consensus earnings upgrades of 4-6%. The company also aims to generate £2.7 billion in operating capital over the next three years, a figure that aligns with previous achievements but is considered higher quality due to a larger proportion being underlying. Furthermore, MNG has formalized a progressive dividend policy, announcing a 2% rise in dividends per share (DPS) for FY25, which is in line with consensus expectations of approximately 3% growth per annum through FY27. RBC analysts commented on the company's financial guidance, stating, "MNG’s new operating capital generation guidance (OCG) implies small downgrades to consensus, once new business capital strain is considered. However, it remains strong enough to underpin MNG’s confidence to commit to a progressive dividend policy, while also continuing to invest in the business (via higher Life new business capital strain)." Related Articles MNG stock rises on strong FY24 results and upbeat targets Exor NV lifts stake in Philips to 18.7% Adyen and AstraZeneca gain TD Cowen's Best Ideas recognition on growth potential View Comments
MNG stock rises on strong FY24 results and upbeat targets
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...